LAMEA Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type (Post-exposure Prophylaxis, and Pre-exposure prophylaxis), By End User, By Application (Human, and Animal), By Product Type, By Country and Growth Forecast, 2023 - 2030

The Latin America, Middle East and Africa Rabies Vaccine Market would witness market growth of 7.0% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $33.5 Million by 2030. The Argentina market is showcasing a CAGR of 7.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 6.6% during (2023 - 2030).



Ongoing research focuses on improving the formulation of these vaccines to enhance their efficacy and duration of immunity. Novel adjuvants and vaccine platforms are being explored to stimulate a robust and long-lasting immune response. These advancements aim to optimize the effectiveness of rabies vaccination campaigns and reduce the frequency of booster doses, particularly in resource-constrained settings.

Technology plays a crucial role in modernizing rabies prevention efforts. Digital health solutions, including mobile applications and digital platforms, are increasingly used for surveillance, reporting, and monitoring of rabies cases. Real-time data collection allows for more agile responses to outbreaks, facilitates targeted vaccination campaigns, and contributes to the overall efficiency of rabies control programs.

Saudi Arabia enforces mandatory pet vaccination policies, requiring pet owners to ensure their animals are vaccinated against rabies. Implementing these policies contributes to a consistent demand for these vaccines, particularly in urban and suburban areas with a higher pet population in Saudi Arabia. The increasing trend of pet ownership in Saudi Arabia, particularly in urban areas, contributes to the demand for these vaccines. As more households adopt pets, responsible ownership practices, including vaccination, become integral to the well-being of animals and public health in Saudi Arabia. As a global hub, Saudi Arabia experiences cross-border travel with pets and imports of animals. Cultural values in Saudi Arabia emphasize the importance of animal welfare. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.

Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Limited
• Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
• Elanco Animal Health, Inc.
• Zoetis, Inc.
• Merck & Co., Inc.
• Novartis AG
• Bharat Biotech Ltd.
• Sanofi S.A.
• Virbac

Market Report Segmentation

By Prophylaxis Type

• Post-exposure Prophylaxis
• Pre-exposure prophylaxis

By End User

• Hospitals
• Veterinary Clinics
• Others

By Application

• Human
• Animal

By Product Type

• Chick Embryo Cells Rabies Vaccine
• Human Diploid Cell Vaccine
• Vero cell rabies vaccine
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA